GLYBURIDE
- Product NDC
- 51655-659
- 11-digit product format
- 516550659
- Labeler code
- 51655
- Product ID
- 51655-659_4b8239f0-5467-fb1e-e063-6294a90a7679
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GLYBURIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA090937
- Marketing category
- ANDA
- Marketing start
- 2021-03-23
- Substance
- GLYBURIDE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GLYBURIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GLYBURIDE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SX6K58TVWC |
| Rxcui | 310534 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51655-659-52 | GLYBURIDE | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-659 | GLYBURIDE TABLET [NORTHWIND PHARMACEUTICALS] | 1 | Current NDC, 1 package rows | 20230321_db47a517-f8bb-136f-e053-2a95a90ad8c5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 51655-659-52 | 51655065952 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-659-52) | 30 tablet | 2021-03-23 | No | No | Current |